FDA
-
-
-
-
-
-
-
XORTX plans FDA IND filing for gout drug in Q4 2026
-
-
-
-
-
-
-
CDT Equity partners with QIMA to test tapinarof drug combinations
-
-
-
-
-
-
-
Biogen's Empaveli cuts proteinuria 75% in teens with rare kidney disease
-
-
-
-
-
-
-
Lexaria raises $7.9M, extends cash runway through 2027
-
-
-
-
-
-
-
Sidus Space signs MOU with Slovenia's 3GM Plus on satellite program
-
-
-
-
-
-
-
Clearmind Medicine testifies at FDA psychedelic hearing in D.C.
-
-
-
-
-
-
-
Aethlon Medical to merge with North Immunology in $346.5M deal
-
331,396 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

